Reconsidering on the drug therapy of adult laryngopharyngeal reflux disease
10.3760/cma.j.issn.1673-0860.2018.08.017
- VernacularTitle: 关于成人咽喉反流性疾病药物治疗的再思考
- Author:
Juanjuan HU
1
;
Meijun ZHENG
1
;
Yuan CHEN
2
;
Lingyu YU
1
;
Hui YANG
1
Author Information
1. Department of Otorhinolaryngology Head and Neck Surgery, West China Hospital, Sichuan University, Chengdu 610041, China
2. West China School of Stomatology, Sichuan University, Chengdu 610041, China
- Publication Type:Review
- Keywords:
Laryngopharyngeal reflux;
Drug therapy
- From:
Chinese Journal of Otorhinolaryngology Head and Neck Surgery
2018;53(8):635-639
- CountryChina
- Language:Chinese
-
Abstract:
The treatment for laryngopharyngeal reflux diseases consist of general treatment, medical therapy and surgical treatment, among which, drug therapy is still the main effective way. Proton pump inhibitor is adopted as the first drug for patients with laryngopharyngeal reflux disease only caused by acid reflux. With standardized treatment, the majority of symptoms in laryngopharyngeal reflux disease could be alleviated effectively. PPI therapy, while seeming logical, is less useful in patients with reflux hypersensitivity, weak acid or non acid reflux, neuropsychic factors and gastroesophageal reflux disease. This article aims to investigate bewilderment and challenge faced by clinicians when managing adult laryngology reflux disease with medical therapy.
